Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Castle Biosciences, Inc. (CSTL) had Receiveable Turnover of 6.48 for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$332.07M |
|
$18.25M |
|
$60.20M |
|
$271.86M |
|
$323.40M |
|
$8.67M |
|
$12.89M |
|
$21.56M |
|
$21.56M |
|
$18.25M |
|
$18.25M |
|
$18.25M |
|
$18.25M |
|
$8.67M |
|
$17.98M |
|
27.78M |
|
29.25M |
|
$0.66 |
|
$0.62 |
|
| Balance Sheet Financials | |
$360.15M |
|
$51.12M |
|
$171.08M |
|
$531.24M |
|
$49.39M |
|
$9.74M |
|
$26.01M |
|
$75.40M |
|
$455.83M |
|
$349.61M |
|
$455.83M |
|
28.48M |
|
| Cash Flow Statement Financials | |
$64.87M |
|
$-50.14M |
|
$6.14M |
|
$98.84M |
|
$119.71M |
|
$20.87M |
|
$50.32M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.29 |
|
-- |
|
-- |
|
0.02 |
|
0.02 |
|
81.87% |
|
2.61% |
|
2.61% |
|
5.42% |
|
6.49% |
|
5.49% |
|
$36.56M |
|
-- |
|
-- |
|
-- |
|
0.63 |
|
7.40 |
|
|
Receiveable Turnover |
6.48 |
56.30 |
|
4.00% |
|
5.22% |
|
3.43% |
|
3.92% |
|
$16.00 |
|
$1.25 |
|
$2.22 |
|